Browse this site http://www.cannabisscience.com/index.php/news-media/cbis-latest-news for more information on cannabis on the stock market. Cannabis on the stock market is at its best. Investors are jumping in to make investments. The founders have been committed to fostering and maintaining a bold, pioneering spirit fostering the true nature of innovation from which cutting edge ideas flourish and translated into evidence-based solutions.Follow us http://storify.com/CannabisPenny

1. Cannabis
On The
Stock
Market
Cannabis sativa is one of the
most widely used plants for
both recreational and medicinal
purposes. To date a total of 525
natural constituents covering
several chemical classes have
been isolated and identified
from Cannabis sativa. The
cannabinoids belong to the
chemical class of
terpenophenolics, of which 85
have been uniquely identified in
cannabis, including the most
psychoactive cannabinoid,
tetrahydrocannabinol
commonly referred to as THC.
Cannabis Science, Inc.
takes advantage of its
unique understanding of
metabolic processes to
provide innovative
treatment options for
unmet medical needs.

2. Cannabis Stock
Market
Cannabis On The
Stock Market
Cannabis Companies
Stock Market
Our team of scientists will produce and commercialize
products derived from cannabis-based botanical
extracts. Even today, new uses for cannabinoids are
consistently discovered. For example, scientists
recently found that topical cannabinoid-based
preparations can be effective against MRSI, the deadly
antibiotic-resistant flesh-eating disease. Other topical
applications, which are largely non-psychoactive, would
target localized pain, such as arthritis and burns, as well
as neuropathic pain, for which there are few effective
treatments.

3. Cannabis Stock Market
Our team of scientists will produce and commercialize
products derived from cannabis-based botanical
extracts. Even today, new uses for cannabinoids are
consistently discovered. For example, scientists
recently found that topical cannabinoid-based
preparations can be effective against MRSI, the deadly
antibiotic-resistant flesh-eating disease. Other topical
applications, which are largely non-psychoactive, would
target localized pain, such as arthritis and burns, as well
as neuropathic pain, for which there are few effective
treatments.
The Company works with leading
experts in drug development,
medicinal characterization, and
clinical research to develop, produce
and commercialize novel therapeutic approaches for
the treatment of multiple critical ailments from cancer
and infections to age-related illnesses and
neurobehavioral disorders.

4. Cannabis Stock Market
In 2001, an article published in the Canadian Medical
Association Journal revealed that, based on self-
identified needs, it is estimated that 2% (or 400,000) of
Canadian adults were already utilizing cannabinoids for
medical purposes. With ever increasing use and
scientific support for cannabinoid medicines occurring in
the US and around the world, we are looking at a new
multi-billion dollar industry that will play a dramatic role
that will impact human health on a global scale.

5. Cannabis
On The
Stock
Market
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S.
company specializing in the development of cannabis-
based medicines, today announced their sponsorship of
the "We Cann Mix" event, which is a mixer event
intended for patients, advocates, entrepreneurs,
scientists, and other enthusiastic members of the
cannabis community.
The Joey Network App in collaboration with CannILiv are
the primary hosts of this event. The fact The Joey
Network App is involved, is one of the reasons Cannabis
Science was able to attain such a premiere sponsorship
opportunity at the event. The Joey Network App is
Cannabis Science Scientific Advisory Board Member
Mieko Hester-Perez's cannabis treatment-centered
smartphone app.

6. Cannabis On The Stock Market
Cannabis Science, Inc., takes advantage of its unique
understanding of metabolic processes to provide novel
treatment approaches to a number of illnesses for which
current treatments and understanding remain
unsatisfactory. Cannabinoids have an extensive history
dating back thousands of years, and currently, there are
a growing number of peer-reviewed scientific
publications that document the underlying biochemical
pathways that cannabinoids modulate.
The Company works with leading experts in drug
development, medicinal characterization, and clinical
research to develop, produce, and commercialize novel
therapeutic approaches for the treatment for illnesses
caused by infections as well as for age-related illness.
Our initial focus is on skin cancers,
HIV/AIDS, and neurological
conditions. The Company is
proceeding with the research and
development of its proprietary
drugs as a part of this initial focus:
CS-S/BCC-1, CS-TATI-1, and CS-
NEURO-1, respectively.

7. Cannabis Companies
Stock Market
The Company works with leading experts in drug
development, medicinal characterization, and
clinical research to develop, produce, and
commercialize novel therapeutic approaches for the
treatment of multiple critical ailments from cancer
and infections to age-related illnesses and
neurobehavioral disorders.

8. Cannabis Companies
Stock Market
At Cannabis Science, we use an inquiring approach to
discover and develop novel cannabinoid-based
therapies to improve patients’ lives. From the initiation,
our founders have been committed to fostering and
maintaining a bold, pioneering spirit fostering the true
nature of innovation from which cutting edge ideas
flourish and translate into evidence-based solutions.
Cannabinoid receptors in the human body were not
discovered until 1988. CB1 receptors are found
throughout the body and are the most prevalent
neurotransmitter system in the brain, specifically in the
basal ganglia and in the limbic system, including the
hippocampus. They are also found in the cerebellum
and in both male and female reproductive systems.

9. Cannabis Companies
Stock Market
Science increasingly recognizes the role that endo-
cannabinoids play in major life functions in the human
body. Cannabinoids act as a bio regulatory mechanism,
which explains why they have been recommended as a
treatment for many diseases and ailments in anecdotal
reports and scientific literature. Common prescribed
ailments include: Pain, arthritic conditions, migraine
headaches, anxiety, epileptic seizures, insomnia, loss of
appetite, GERD (chronic heartburn), nausea, glaucoma,
AIDS wasting syndrome, depression, bipolar disorder
(particularly depression-manic-normal), multiple
sclerosis, menstrual cramps, Parkinson's, trigeminal
neuralgia (tic douloureux), high blood pressure, irritable
bowel syndrome, and bladder incontinence.

10. Cannabis Science
Inc Stock News
www.cannabisscience.com
For more information visit our website